Evercore ISI reiterates Constellation Brands stock rating on guidance By Investing.com

Evercore ISI reiterated an Outperform on Constellation Brands (STZ) with a $170 target while the stock trades at $150.26 and analyst targets range from $120 to $220. Management forecasts beer net sales of -1% to +1% for FY2027 (volumes -3% to flat, pricing +1% to +2%), prompting questions about conservative guidance and capital allocation under the new CEO. Multiple brokers (UBS $176, Goldman $180, RBC $185, Roth/MKM $209) remain constructive, though some EPS estimates sit below consensus, leaving a cautiously positive analyst backdrop that may move the stock modestly rather than the broader market.

Analysis

Constellation’s conservative near-term outlook looks like deliberate messaging to preserve optionality for capital allocation under a new CEO rather than a pure demand signal. If management pivots to buybacks or selective M&A, EPS could re-rate materially without a meaningful change in volumes — a 5-10% reduction in share count would meaningfully boost per-share metrics given the firm’s cash profile.

Second-order beneficiaries of any modest beer-volume weakness are packaging and hop suppliers whose volumes are lumpy and tied to seasonal events; conversely, premiumization exposure (higher ASP SKUs) benefits from depletions/consumption mix improving, which would lift gross margins before top-line growth returns. Retailers and on-premise operators will adjust promotions and inventory cadence around event-driven windows, creating short-term volatility in distributor shipments vs. long-term depletion trends.

Key catalysts are the company call/earnings (days–weeks), revealed capital allocation plans (months), and consumption/depletion readthroughs around large sporting windows (quarters). Tail risks that would reverse any constructive stance include a persistent on-premise demand shortfall, a sharp raw-material inflation spike, or an unexpected shift in Mexico currency or regulatory environment — any of which could eliminate the buyback optionality and compress multiples over 6–24 months.

Key Decisions for Investors

• Tactical bullish options spread on STZ ahead of the next quarterly call: buy a 3-month call 25% OTM and sell a 3-month call 40% OTM sized so premium = ~1–2% of notional. Rationale: asymmetric payout to capture a guidance surprise or favorable capital-allocation tone; max loss = premium, target 8–15% equity-equivalent upside (4–8x R/R).
• Buy-and-hedge core position: acquire STZ shares with a 6–12 month protective put 15% OTM. Timeframe: hold 6–18 months for capital-allocation actions to surface; payoff: protects downside (~15%) while leaving room for 20–35% upside if buybacks/M&A drive re-rating. Cost of hedging expected ~2–4% of position value.
• Relative-value pair: long STZ / short TAP (equal-dollar) for 6–12 months to express premiumization and international portfolio strength vs. domestic regional exposure. Target: 10–20% relative outperformance; risk: category-wide weakness that hurts both legs, cut position if both underperform by >12% in 1 month.
• Income alternative for neutral view: sell 3–6 month covered calls on STZ with strikes 15–20% above market to collect yield while retaining upside optionality. Expect to earn 3–6% premium in the near term; exit if management signals aggressive buybacks (take profits) or if share underperformance exceeds 10%.